3 Small Biotech Stocks Being Run by Proven Winners
Great leaders are important in any industry, but perhaps they're even more valuable in biotech, where any number of clinical-stage and regulatory obstacles can derail drug research and send share prices reeling. For that reason, investing in biotech stocks such as Aurinia Pharmaceuticals (NASDAQ: AUPH), Axovant Sciences (NYSE: AXON), and Esperion Therapeutics (NASDAQ: ESPR) -- all of which are run by proven leaders -- could be savvy.
Aurinia Pharmaceuticals' C-suite is packed with ex-Aspreva Pharmaceuticals executives who know a thing or two about lupus nephritis (LN).
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Pfizer Inc. Stock
€27.41
1.290%
With 49 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 33 € there is a positive potential of 20.42% for Pfizer Inc. compared to the current price of 27.41 €.
